These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 7648385

  • 1. Long-acting beta 2-agonist salmeterol compared with albuterol in maintenance asthma therapy.
    Pearlman DS.
    Ann Allergy Asthma Immunol; 1995 Aug; 75(2):180-4. PubMed ID: 7648385
    [Abstract] [Full Text] [Related]

  • 2. A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma.
    Pearlman DS, Chervinsky P, LaForce C, Seltzer JM, Southern DL, Kemp JP, Dockhorn RJ, Grossman J, Liddle RF, Yancey SW.
    N Engl J Med; 1992 Nov 12; 327(20):1420-5. PubMed ID: 1357554
    [Abstract] [Full Text] [Related]

  • 3. Safety of salmeterol in the maintenance treatment of asthma.
    Nathan RA, Seltzer JM, Kemp JP, Chervinsky P, Alexander WJ, Liddle R, Mills R.
    Ann Allergy Asthma Immunol; 1995 Sep 12; 75(3):243-8. PubMed ID: 7552926
    [Abstract] [Full Text] [Related]

  • 4. Efficacy, safety, and effects on quality of life of salmeterol versus albuterol in patients with mild to moderate persistent asthma.
    Wenzel SE, Lumry W, Manning M, Kalberg C, Cox F, Emmett A, Rickard K.
    Ann Allergy Asthma Immunol; 1998 Jun 12; 80(6):463-70. PubMed ID: 9647268
    [Abstract] [Full Text] [Related]

  • 5. Efficacy, safety, and impact on quality of life of salmeterol in patients with moderate persistent asthma.
    Busse WW, Casale TB, Murray JJ, Petrocella V, Cox F, Rickard K.
    Am J Manag Care; 1998 Nov 12; 4(11):1579-87. PubMed ID: 10338904
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A comparison of the efficacy of long-acting beta 2-agonists: eformoterol via Turbohaler and salmeterol via pressurized metered dose inhaler or Accuhaler, in mild to moderate asthmatics. Force Research Group.
    Campbell LM, Anderson TJ, Parashchak MR, Burke CM, Watson SA, Turbitt ML.
    Respir Med; 1999 Jul 12; 93(7):236-44. PubMed ID: 10464829
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Salmeterol compared with current therapies in chronic asthma.
    Adinoff AD, Schwartz HJ, Rickard KA, Yancey SW, Swearingen BE.
    J Fam Pract; 1998 Oct 12; 47(4):278-84. PubMed ID: 9789513
    [Abstract] [Full Text] [Related]

  • 12. Comparative study of extended release albuterol sulfate and long-acting inhaled salmeterol xinafoate in the treatment of nocturnal asthma.
    Martin RJ, Kraft M, Beaucher WN, Kiechel F, Sublett JL, LaVallee N, Shilstone J.
    Ann Allergy Asthma Immunol; 1999 Aug 12; 83(2):121-6. PubMed ID: 10480584
    [Abstract] [Full Text] [Related]

  • 13. Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma.
    Cheung D, Timmers MC, Zwinderman AH, Bel EH, Dijkman JH, Sterk PJ.
    N Engl J Med; 1992 Oct 22; 327(17):1198-203. PubMed ID: 1357550
    [Abstract] [Full Text] [Related]

  • 14. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL, Boulet LP, Keith PK, Scott-Wilson CA, House KW, Dorinsky PM.
    Clin Ther; 2007 Jul 22; 29(7):1390-402. PubMed ID: 17825690
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of salmeterol xinafoate powder in children with chronic persistent asthma.
    Weinstein SF, Pearlman DS, Bronsky EA, Byrne A, Arledge T, Liddle R, Stahl E.
    Ann Allergy Asthma Immunol; 1998 Jul 22; 81(1):51-8. PubMed ID: 9690573
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [efficacy and safety of salmeterol in long-term therapy in patients with chronic obstructive airway diseases].
    Beeh KM, Wiewrodt R, Salem AE, Buhl R.
    Pneumologie; 2000 Jun 22; 54(6):225-31. PubMed ID: 10934892
    [Abstract] [Full Text] [Related]

  • 18. Salmeterol xinafoate: a review of its pharmacological properties and therapeutic potential in reversible obstructive airways disease.
    Brogden RN, Faulds D.
    Allergol Immunopathol (Madr); 1992 Jun 22; 20(2):72-84. PubMed ID: 1359777
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Usefulness of salmeterol in nocturnal asthma: a comparative study with theophylline-ketotifen association. A French multicenter group].
    Muir JF, Georges D.
    Rev Mal Respir; 1992 Jun 22; 9 Suppl 1():R23-6. PubMed ID: 1350366
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.